Kaufman joins AccuImage
MRI pioneer Leon Kaufman, Ph.D., has taken the helm of AccuImage Diagnostics. Kaufman joined the company as CEO in mid-February, leaving Toshiba amid that company's reorganization (SCAN 1/31/01). Kaufman in 1975 established one of the world's first MRI
MRI pioneer Leon Kaufman, Ph.D., has taken the helm of AccuImage Diagnostics. Kaufman joined the company as CEO in mid-February, leaving Toshiba amid that company's reorganization (SCAN 1/31/01). Kaufman in 1975 established one of the world's first MRI development programs at the University of California, San Francisco, a program successively supported by Pfizer, Diasonics, and Toshiba America, as well as the National Institutes of Health. After leaving UCSF in 1994, Kaufman spent six years as Toshiba's chief scientist and vice president of engineering. In his new position at AccuImage, Kaufman will focus on the development and marketing of 3-D visualization and networking technology.
2/28/01, Issue # 1504, page 4.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.
